UBS Group
LDL

UBS Group’s Lydall, Inc. LDL Stock Holding History

UBS Group’s Portfolio LDL Stock Details LDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-100
Closed -$3K – 8982
2015
Q1 		$3K Hold
100
– – ﹤0.01% 8363
2014
Q4 		$3K Buy
+100
New +$2.89K ﹤0.01% 9299

UBS Group's LDL Position: Q4 2021 in Review

UBS Group sold out of Lydall, Inc. (LDL) in Q4 2021, closing a stake of 634 shares — an estimated $39K sold.

UBS Group first reported a position in LDL in Q4 2014 and held it in 28 quarters. The position peaked at $513K in Q4 2019. 1 fund tracked by Wall St. Rank holds LDL as of Q4 2021.

  • UBS Group reported no remaining Lydall, Inc. position as of Q4 2021 after selling out during the quarter.
  • UBS Group sold 634 Lydall, Inc. shares in Q4 2021, an estimated $39K.
  • UBS Group first reported a position in Lydall, Inc. in Q4 2014 and held it in 28 quarters.
  • UBS Group's Lydall, Inc. position peaked at $513K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Lydall, Inc. as of Q4 2021.

Based on UBS Group's 13F filing for Q4 2021, filed 14 Feb 2022.